Clinical trial
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
NCT00019123 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019123 |
|---|---|
| Title | Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma |
| Official title | A PHASE II STUDY OF ORAL THALIDOMIDE FOR PATIENTS WITH HIV INFECTION AND KAPOSI'S SARCOMA |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | thalidomide |
| Start date | Apr 1, 1996 |
| Completion | Apr 1, 2004 |
| First posted | Apr 13, 2004 |
| Last update posted | Aug 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: